Τίτλος:
Management of Atrial Fibrillation in Patients With Heart Failure
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
Background: There is a well-documented relationship and a complex interaction between atrial fibrillation (AF) and heart failure. The coexistence of these 2 clinical entities renders their management even more challenging. Methods and results: We searched current literature to review the management of AF in patients with heart failure. The cornerstones of AF treatment are rate control, cardioversion, and maintenance of sinus rhythm (SR), and prevention of thromboembolism. The issue of rhythm versus rate control remains unresolved. Nonpharmacologic therapies such as radiofrequency catheter ablation of the atrioventricular node with permanent pacemaker implantation, curative catheter ablation of AF, and cardiac resynchronization therapy are emerging and may alter the management of these patients. Conclusion: Treatment of atrial fibrillation in the setting of heart failure encompasses a variety of approaches including drugs, devices, and ablation. Larger randomized trials are required to clarify the management of such patients. © 2008 Elsevier Inc. All rights reserved.
Συγγραφείς:
Efremidis, M.
Pappas, L.
Sideris, A.
Filippatos, G.
Περιοδικό:
Journal of Cardiac Failure
Λέξεις-κλειδιά:
acetylsalicylic acid; amiodarone; angiotensin 1 receptor; antivitamin K; beta adrenergic receptor blocking agent; bisoprolol; carvedilol; digoxin; diltiazem; dofetilide; esmolol; hydroxymethylglutaryl coenzyme A reductase inhibitor; ibutilide; metoprolol; metoprolol tartrate; verapamil; warfarin, artificial heart pacemaker; bradycardia; cardiac resynchronization therapy; cardiovascular risk; cardioversion; catheter ablation; clinical trial; combination chemotherapy; defibrillator; drug efficacy; drug potentiation; drug withdrawal; heart atrioventricular node; heart atrium fibrillation; heart failure; heart left ventricle ejection fraction; heart left ventricle failure; heart rate; human; monotherapy; morbidity; mortality; priority journal; quality of life; recurrence risk; review; sinus rhythm; thromboembolism; torsade des pointes; unspecified side effect, Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Combined Modality Therapy; Electrocardiography; Female; Heart Failure; Humans; Male; Prognosis; Randomized Controlled Trials as Topic; Recurrence; Risk Assessment; Severity of Illness Index; Survival Analysis; Treatment Outcome
DOI:
10.1016/j.cardfail.2007.10.023
